EGFR and breast carcinoma: However, the results revealed that knockdown of Akt1 in MCF-7 and MDA-MB-231 cells failed to promote the mRNA expression of EGFR (Fig. 3c), suggesting that additional target is contributing to the overexpression of EGFR in Akt1 impaired breast cancer cells.